PEBP board hears actuarial warning on reserves, orders analyses on plan design and pharmacy costs
Loading...
Summary
The Public Employees Benefits Program Board met Friday and, after actuarial briefings and public comment warning of a reserves shortfall, directed staff and its actuary to return with detailed cost and operational analyses on multiple plan‑design and pharmacy proposals. The board also adopted interim policy edits, extended two vendor contracts, and directed distribution of an HMO medical‑loss‑ratio rebate.
The Public Employees Benefits Program Board met Friday morning and spent much of the session on financial briefings and potential plan‑design changes after the actuarial firm Segal reported near‑term reserve shortfalls and long‑term retiree‑health liabilities.
Segal principal Richard Ward told the board that enrollment has shifted toward the low‑deductible PPO while the consumer‑directed health plan (CDHP) remains the single largest enrollment pool. Segal cited rising pharmacy trend driven by specialty drugs — including GLP‑1 agents — and a medical trends environment that warrants continued caution. The board was shown that fiscal year 2025 cash on hand dropped to about $67 million, while a set of actuarial reserve targets (IBNR, catastrophic and HRA protections) produced a combined funding need staff and public commenters described as deficient by tens of millions of dollars.
Why it matters: Board members and public commenters said they want reserves restored over a reasonable timetable without cutting core benefits. Segal and staff described a range of tools — from rate adjustments and subsidy policy changes to targeted pharmacy steps — that could help stabilize the fund while balancing member affordability.
The board took several discrete actions and instructions:
- Interim policies/procedures: The board adopted the staff‑proposed edits to the board's policies and procedures (updates reflecting SB 494 and other corrections) and directed staff to return appendix A (rate‑setting and reserve detail) for more detailed review at the November meeting. (Motion: adopted; voice vote.)
- Master plan documents: The board approved MPD clarifications that are properly noticed for plan year 2026 (items clarifying condom reimbursement, circumcision prior‑auth rules, and an updated claims‑timing requirement under AB 52 effective 1/1/2026). More substantive MPD changes tied to fiscal notes (fertility preservation under AB 428 and genetics counseling under SB 344) were not acted on today and will return with fiscal analysis. (Motion: approved sections 1 & 2 for plan year 2026; voice vote.)
- Direct actuarial and staff analyses: The board voted to have Segal and staff return in November with cost and implementation analyses on a menu of proposals, including a medical/pharmacy coupon program (UMR/SaveOn‑style), review of prior‑authorization requirements (starting with biopsies and other PAs with near‑100% approval rates), 100% coverage for diagnostic breast imaging and colonoscopy (except for HSA/IRS limits), enhanced member education for network lab use, vision‑benefit updates (frames/annual maximum and network options), pharmacy cost‑share redesign (nonpreferred brand structure), and a 3‑tier specialty strategy to incentivize biosimilar adoption. (Motions: directed analyses; voice votes.)
- Long‑term disability (LTD) inquiry: The board asked staff to return a quote and fiscal impact for reinstating LTD as part of the core or voluntary benefits mix. (Motion: request quote; voice vote.)
- Contracts: The board approved two contract extensions (HSA Bank and UnitedHealthcare basic life) through 06/30/2028, as recommended by staff. (Motion: approved; voice vote.)
- HMO medical‑loss‑ratio rebate: Health Plan of Nevada notified the PEBP group of a required rebate of approximately $891,000. Using the statutory allocation approach, staff calculated the portion attributable to HMO members (about $257,000). The board directed staff to provide that member share as a one‑time premium credit; staff indicated that a single premium table modification to lower the HMO subscriber premium for a defined period is the most administratively straightforward option and directed non‑state employers to pass any allocated rebate to their employees. (Motion: apply premium credit and instruct employers to pass funds; voice votes.)
Board members repeatedly emphasized two near‑term priorities voiced in public comment: (1) avoid benefit reductions for retirees and active employees where possible; and (2) replenish reserves, preferably over a realistic multi‑year period unless legislative dollars are provided.
What happens next: Staff and Segal will return with the detailed cost and operational analyses requested in November. Those analyses will include projected impacts on premiums, member contributions, reserve rebuild timing, and access changes if plan options are altered. The board scheduled follow‑up on Appendix A (rate‑setting) and on a strategic‑plan discussion tied to the Nevada Health Authority's ongoing strategic plan work.
Quotes: "We now have the final budget as of the close of fiscal year 2025. The actuarial mandatory reserves were 55,400,000 for IBNR at 95% confidence, 47,000,000 for catastrophic at 50 days of claims, and 20.6 million for the HRA at 80% of balances," public commenter Kent Ervin said during the first public comment period. "That totals about $123 million; cash on hand dropped to about $67 million, meaning reserves were deficient by roughly $56 million," Ervin added (public comment).
Ending: The board adjourned after completing agenda business and directing the actuarial and staff work noted above. The next meeting was scheduled to include financial impacts and detailed proposals so the board could consider formal plan‑design changes before final rate setting.
